IL-20 activates human lymphatic endothelial cells causing cell signalling and tube formation.
IL-20 is an arteriogenic cytokine that remodels collateral networks in vivo, and plays a role in cellular organization. Here, we investigate its role in lymphangiogenesis using a lymphatic endothelial cell line, hTERT-HDLEC, which expresses the lymphatic markers LYVE-1 and podoplanin. Upon stimulation of hTERT-HDLEC with IL-20, we found an increase in the intracellular free calcium concentration, in Akt and eNOS phosphorylations as well as in perinuclear NO production. We found that eNOS phosphorylation and NO synthesis are highly dependent on the PI3K/Akt signalling pathway. We also found an IL-20 induced phosphorylation of Erk1/2 and mTOR, and using the MEK inhibitor PD98059 and mTOR complex inhibitor rapamycin we demonstrated the importance of these signalling pathways in IL-20-mediated proliferation. IL-20 triggered actin polymerization and morphological changes resulting in elongated cell structures, and in matrigels, IL-20 caused tube formations of hTERT-HDLEC in a PI3K- and mTOR dependent way. In a sprouting assay we found that IL-20 caused cell migration within 24 h at a rate comparable to VEGF-C, and this migration could be inhibited by wortmannin and rapamycin. These data show that IL-20 activates cell signalling resulting in lymphangiogenic processes including migration, proliferation and tube formation. Thus, IL-20 is a cytokine that has the potential of activating or modulating the formation of lymphatic vessels.
Hammer
Troels
T
Department of Cellular and Molecular Medicine, Faculty of Health Sciences, Center for healthy Ageing, University of Copenhagen, Denmark.
Tritsaris
Katerina
K
Hübschmann
Martin V
MV
Gibson
Josefine
J
Nisato
Riccardo E
RE
Pepper
Michael S
MS
Dissing
Steen
S
D002460:Cell Line; D042783:Endothelial Cells / Q000187:drug effects*; D004729:Endothelium, Lymphatic / Q000187:drug effects*; D006801:Humans; D007378:Interleukins / Q000235:genetics / Q000494:pharmacology*; D042583:Lymphangiogenesis / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects*
D007378:Interleukins; D011994:Recombinant Proteins; C422042:interleukin 20